• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Obituary Notice: Russell “Russ” Haines

    Abenza Chooses North Carolina for New Biologics Manufacturing Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Arkema Recruits Dotmatics as its R&D Digitalization Partner
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    PCI Pharma Services

    Quotient Sciences

    Reed-Lane

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Baxter BioPharma Solutions

    PCI Pharma Services

    Reed-Lane

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Alvotech and Fuji Pharma Enter Biosimilars Tie-up

    Partnership gives Fuji Pharma a leading position in the Japanese biosimilar market

    Alvotech and Fuji Pharma Enter Biosimilars Tie-up
    Fuji Pharma's president and CEO, Eiji Takamasa, alongside Alvotech's chief executive, Rasmus Rojkjaer
    Related CONTENT
    • Vetio Animal Health
    • Rexahn Announces New CEO
    • Streamlining Drug Development:
    • AstraZeneca Sells Infant Drug Rights for $1.5B
    • Rigel & Kissei Enter Agreement
    11.20.18
    Alvotech and Fuji Pharma are entering into an exclusive partnership for the commercialization by Fuji Pharma of Alvotech’s biosimilar portfolio in Japan.
     
    Alvotech will be responsible for development and supply of multiple high value biosimilar assets from its current product pipeline, while Fuji Pharma will be responsible for registration and commercialization of these assets in Japan. Alvotech’s biosimilar portfolio includes high value products used in advanced therapies of oncology, ophthalmology and autoimmune disease that generated over $32 billion in global sales in 2017, according to Evaluate data.
     
    The partnership has been made with a view to establishing a long-term relationship that also gives Fuji Pharma the opportunity to invest in Alvotech’s capital structure. In partnering with Fuji Pharma, Alvotech will gain access to Japan’s fast-growing biosimilars market, forecasted to grow as much as 35% CAGR over the next years. 
     
    “We are very proud to announce our strategic alliance with Fuji Pharma, a pioneer in the Japanese biosimilars market,” said Rasmus Rojkjaer, chief executive officer, Alvotech. “We strongly believe that in combining Alvotech’s significant manufacturing capacity and high value biosimilars portfolio with Fuji Pharma’s deep market experience, we will together be staking a place as leaders in Japan’s rapidly growing biosimilars market. We are excited to continue delivering on our expanding commitment to bring high quality biosimilars to patients worldwide.”
     
    Eiji Takamasa, president and chief executive officer, Fuji Pharma, said, “Both Fuji Pharma and Alvotech share the same management philosophy that fuels our excitement to partner with each other. Together we will ensure that patients in Japan will get high quality biosimilars, while reducing the cost burden on the aging Japanese society.  Fuji Pharma’s strong market reach in Japan, complemented with Alvotech’s futuristic portfolio of the expected first-to-launch biosimilar products, will provide the critical synergies for the success of this partnership.”
    Related Searches
    • Manufacturing
    • capacity
    • Development
    • biosimilar
    Suggested For You
    Vetio Animal Health Vetio Animal Health
    Rexahn Announces New CEO Rexahn Announces New CEO
    Streamlining Drug Development: Streamlining Drug Development:
    AstraZeneca Sells Infant Drug Rights for $1.5B AstraZeneca Sells Infant Drug Rights for $1.5B
    Rigel & Kissei Enter Agreement Rigel & Kissei Enter Agreement
    AptarGroup Appoints CHRO AptarGroup Appoints CHRO
    Abzena Names New CEO Abzena Names New CEO
    IDT Biologika Awarded 10-Year NIH Contract IDT Biologika Awarded 10-Year NIH Contract
    Vasomune Appoints New CEO Vasomune Appoints New CEO
    Nautic Partners Acquires Mikart Nautic Partners Acquires Mikart
    LakePharma Announces "New Frontiers in Biologics" Conference LakePharma Announces "New Frontiers in Biologics" Conference
    VIVUS Appoints New President VIVUS Appoints New President
    Sinovant, Renexxion to Develop and Commercialize Naronapride Sinovant, Renexxion to Develop and Commercialize Naronapride
    PCI Names Salim Haffar CEO PCI Names Salim Haffar CEO
    Endocyte, ITG Enter Supply Deal Endocyte, ITG Enter Supply Deal

    Related Breaking News

    • Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
      mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity

      mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity

      Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.
      Tim Wright, Editor, Contract Pharma 03.25.21

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech and DKSH Extend Biosimilar Partnership in Asia

      Alvotech and DKSH Extend Biosimilar Partnership in Asia

      Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.
      Contract Pharma Staff 09.24.20

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, DKSH Partner to Bring Biosimilar to Asia

      Alvotech, DKSH Partner to Bring Biosimilar to Asia

      Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech
      03.26.20


    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, JAMP Pharma Ink Biosim Deal

      Alvotech, JAMP Pharma Ink Biosim Deal

      Enter into an exclusive partnership for the commercialization of key biosimilars in Canada.
      01.15.20

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Horizon, Glenmark Sign Biomfg. License Agreement

      Horizon, Glenmark Sign Biomfg. License Agreement

      For GS knockout CHO cell line for manufacture of biotherapeutics
      09.30.19

    • Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance

      Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance

      Lonza’s biologics facility in Singapore to cover EU and U.S. market needs
      09.03.19


    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Alvotech, Prestige Biopharma Enter New Manufacturing Partnership

      Alvotech, Prestige Biopharma Enter New Manufacturing Partnership

      Alvotech Contract Services to make one of Prestige’s biosimilar candidates
      08.28.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Alvotech, Cipla Gulf Ink Biosimilar Deal

      Alvotech, Cipla Gulf Ink Biosimilar Deal

      Will partner for the commercialization of key biosimilar in select emerging markets
      07.29.19

    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Facilities | Industry News
      Celltrion, Nan Fung Group Set Up Bio CDMO in China

      Celltrion, Nan Fung Group Set Up Bio CDMO in China

      Establish Vcell Healthcare to develop and commercialize biosimilars; will open biologics manufacturing facility
      07.19.19


    • Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News
      BioPlan Benchmarks the State of Biopharma Mfg.

      BioPlan Benchmarks the State of Biopharma Mfg.

      Participate in the 16th Annual Biopharma Survey Report!
      03.08.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis, Turgut Expand Biosimilar Development Pact

      Selexis, Turgut Expand Biosimilar Development Pact

      Under new commercial license agreements, Selexis will help advance Turgut’s pipeline of biosim products in oncology
      02.28.19

    • Bio News | Biosimilars | Breaking News
      Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China

      Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China

      C-Bridge forms new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis
      02.11.19


    • Bio News | Biosimilars | Breaking News | Industry News
      Alvotech Raises $300M to Fuel Biosimilar Growth

      Alvotech Raises $300M to Fuel Biosimilar Growth

      Current pipeline consists of six biosimilar monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases
      01.22.19

    • Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
      Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China

      Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China

      Covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart
      12.28.18

    • Biosimilars | Breaking News | Drug Development | Industry News
      Alvotech, Fuji Pharma Expand Biosimilars Alliance

      Alvotech, Fuji Pharma Expand Biosimilars Alliance

      Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan
      12.18.18

    Trending
    • Thermo Fisher Acquires PPD For $17.4B
    • Ensuring Pharma Manufacturing Quality
    • Bristol Myers Squibb Expands At Cambridge Crossing
    • Abenza Chooses North Carolina For New Biologics Manufacturing Site
    • Amgen Completes Five Prime Acquisition
    Breaking News
    • Bristol Myers Squibb Expands at Cambridge Crossing
    • Amgen Completes Five Prime Acquisition
    • Sartorius Expands in the UK
    • Obituary Notice: Russell “Russ” Haines
    • Abenza Chooses North Carolina for New Biologics Manufacturing Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Evonik Highlights Solutions for Malodor Reduction
    P&G Emphasizes Small Actions at Home To Be More Sustainable
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login